153 related articles for article (PubMed ID: 27368109)
1. TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
Yang L; Xin J; Zhang Z; Yan H; Wang J; Sun E; Hou J; Jia X; Lv H
J Pharm Pharmacol; 2016 Sep; 68(9):1109-18. PubMed ID: 27368109
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.
Yang L; Zhang Z; Hou J; Jin X; Ke Z; Liu D; Du M; Jia X; Lv H
Int J Nanomedicine; 2017; 12():7653-7667. PubMed ID: 29089761
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS.
Yan H; Wei P; Song J; Jia X; Zhang Z
J Pharm Pharmacol; 2016 Oct; 68(10):1290-8. PubMed ID: 27465923
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation.
Li J; Cheng X; Chen Y; He W; Ni L; Xiong P; Wei M
Int J Pharm; 2016 Oct; 512(1):262-272. PubMed ID: 27545748
[TBL] [Abstract][Full Text] [Related]
5. Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.
Zhang Y; Tong D; Che D; Pei B; Xia X; Yuan G; Jin X
Int J Nanomedicine; 2017; 12():605-614. PubMed ID: 28144142
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells.
Muthu MS; Kulkarni SA; Xiong J; Feng SS
Int J Pharm; 2011 Dec; 421(2):332-40. PubMed ID: 22001537
[TBL] [Abstract][Full Text] [Related]
7. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Gill KK; Kaddoumi A; Nazzal S
Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
[TBL] [Abstract][Full Text] [Related]
8. Increased antitumor efficacy of ginsenoside Rh
Xia X; Tao J; Ji Z; Long C; Hu Y; Zhao Z
Drug Deliv; 2020 Dec; 27(1):1369-1377. PubMed ID: 32998576
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies.
Kala SG; Chinni S
Drug Deliv Transl Res; 2022 Nov; 12(11):2856-2864. PubMed ID: 35322372
[TBL] [Abstract][Full Text] [Related]
10. TPGS-Modified Long-Circulating Liposomes Loading Ziyuglycoside I for Enhanced Therapy of Myelosuppression.
Song T; Wang H; Liu Y; Cai R; Yang D; Xiong Y
Int J Nanomedicine; 2021; 16():6281-6295. PubMed ID: 34548791
[TBL] [Abstract][Full Text] [Related]
11. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic effect of ginsenoside Rg3 in ICR mouse primary cultures and its application to a biological response modifier.
Joo SS; Won TJ; Kim MS; Lee DI
Fitoterapia; 2004 Jun; 75(3-4):337-41. PubMed ID: 15158992
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles.
Cheng X; Yan H; Jia X; Zhang Z
J Drug Target; 2016; 24(2):161-8. PubMed ID: 26325229
[TBL] [Abstract][Full Text] [Related]
15. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation.
Munyendo WL; Zhang Z; Abbad S; Waddad AY; Lv H; Baraza LD; Zhou J
J Biomed Nanotechnol; 2013 Dec; 9(12):2034-47. PubMed ID: 24266259
[TBL] [Abstract][Full Text] [Related]
16. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
[TBL] [Abstract][Full Text] [Related]
17. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots.
Wang CZ; Aung HH; Ni M; Wu JA; Tong R; Wicks S; He TC; Yuan CS
Planta Med; 2007 Jun; 73(7):669-74. PubMed ID: 17538869
[TBL] [Abstract][Full Text] [Related]
18. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
19. RGD-TPGS decorated theranostic liposomes for brain targeted delivery.
Sonali ; Singh RP; Sharma G; Kumari L; Koch B; Singh S; Bharti S; Rajinikanth PS; Pandey BL; Muthu MS
Colloids Surf B Biointerfaces; 2016 Nov; 147():129-141. PubMed ID: 27497076
[TBL] [Abstract][Full Text] [Related]
20. Oral liposomes encapsulating ginsenoside compound K for rheumatoid arthritis therapy.
Li Z; Han S; Cui G; Xue B; Li J; Man Y; Zhang H; Teng L
Int J Pharm; 2023 Aug; 643():123247. PubMed ID: 37467813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
